Literature DB >> 11970861

Posttranslational mechanisms control the timing of bHLH function and regulate retinal cell fate.

Kathryn B Moore1, Meredith L Schneider, Monica L Vetter.   

Abstract

During central nervous system development, neurons are often born in a precise temporal sequence. Basic helix-loop-helix (bHLH) transcription factors are required for the development of specific subpopulations of neurons, but how they contribute to their ordered genesis is unclear. We show that the ability of bHLH factors to regulate the development of distinct neuronal subtypes in the Xenopus retina depends upon the timing of their function. In addition, we find that the timing of bHLH function can be regulated posttranslationally, so that bHLH factors with overlapping expression can function independently. Specifically, XNeuroD function in the retina can be inhibited by glycogen synthase kinase 3beta (GSK3beta), while Xath5 function can be inhibited by Notch. Thus, the potential of bHLH factors to regulate the development of neuronal subtypes depends upon the context in which they function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970861     DOI: 10.1016/s0896-6273(02)00666-9

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  40 in total

Review 1.  Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies.

Authors:  Ruben Adler; M Valeria Canto-Soler
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

2.  Wnt signaling in eye organogenesis.

Authors:  Sabine Fuhrmann
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

3.  A directional Wnt/beta-catenin-Sox2-proneural pathway regulates the transition from proliferation to differentiation in the Xenopus retina.

Authors:  Michalis Agathocleous; Ilina Iordanova; Minde I Willardsen; Xiao Yan Xue; Monica L Vetter; William A Harris; Kathryn B Moore
Journal:  Development       Date:  2009-10       Impact factor: 6.868

4.  Reprogramming amacrine and photoreceptor progenitors into retinal ganglion cells by replacing Neurod1 with Atoh7.

Authors:  Chai-An Mao; Jang-Hyeon Cho; Jing Wang; Zhiguang Gao; Ping Pan; Wen-Wei Tsai; Laura J Frishman; William H Klein
Journal:  Development       Date:  2013-02-01       Impact factor: 6.868

5.  The ETS transcription factor Etv1 mediates FGF signaling to initiate proneural gene expression during Xenopus laevis retinal development.

Authors:  Minde Willardsen; David A Hutcheson; Kathryn B Moore; Monica L Vetter
Journal:  Mech Dev       Date:  2013-11-09       Impact factor: 1.882

6.  MicroRNAs couple cell fate and developmental timing in retina.

Authors:  Sarah Decembrini; Dario Bressan; Robert Vignali; Letizia Pitto; Sara Mariotti; Giuseppe Rainaldi; Xiumei Wang; Monica Evangelista; Giuseppina Barsacchi; Federico Cremisi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

7.  Pax6 regulation of Math5 during mouse retinal neurogenesis.

Authors:  Amy N Riesenberg; Tien T Le; Minde I Willardsen; David C Blackburn; Monica L Vetter; Nadean L Brown
Journal:  Genesis       Date:  2009-03       Impact factor: 2.487

8.  Temporal regulation of Ath5 gene expression during eye development.

Authors:  Minde I Willardsen; Arminda Suli; Yi Pan; Nicholas Marsh-Armstrong; Chi-Bin Chien; Heithem El-Hodiri; Nadean L Brown; Kathryn B Moore; Monica L Vetter
Journal:  Dev Biol       Date:  2008-11-14       Impact factor: 3.582

9.  Heterochronic misexpression of Ascl1 in the Atoh7 retinal cell lineage blocks cell cycle exit.

Authors:  Robert B Hufnagel; Amy N Riesenberg; Malgorzata Quinn; Joseph A Brzezinski; Tom Glaser; Nadean L Brown
Journal:  Mol Cell Neurosci       Date:  2013-02-26       Impact factor: 4.314

10.  ERK5 MAP kinase regulates neurogenin1 during cortical neurogenesis.

Authors:  Paige Cundiff; Lidong Liu; Yupeng Wang; Junhui Zou; Yung-Wei Pan; Glen Abel; Xin Duan; Guo-Li Ming; Chris Englund; Robert Hevner; Zhengui Xia
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.